Lynn Biderman, Ph.D.
Affiliations: | Biological Sciences | Columbia University, New York, NY |
Area:
p53 tumour suppressor proteinGoogle:
"Lynn Biderman"Mean distance: 12.26 | S | N | B | C | P |
Parents
Sign in to add mentor| Carol L. Prives | grad student | 2012 | Columbia | |
| (Mdm2 and MdmX as Regulators of Gene Expression.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Klein AM, Biderman L, Tong D, et al. (2021) MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53. Proceedings of the National Academy of Sciences of the United States of America. 118 |
| Biderman L, Manley JL, Prives C. (2012) Mdm2 and MdmX as Regulators of Gene Expression. Genes & Cancer. 3: 264-73 |
| Biderman L, Poyurovsky MV, Assia Y, et al. (2012) MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress. Molecular and Cellular Biology. 32: 1214-25 |
| Zhu Y, Poyurovsky MV, Li Y, et al. (2009) Ribosomal protein S7 is both a regulator and a substrate of MDM2. Molecular Cell. 35: 316-26 |